Abstract
This paper reviews the developments of drug delivery with special attention on its controlled release and drug targeting. Finally, the importance of multidisciplinary informations and how they are integrated in a systematically meaningful manner to achieve an optimization of cancer drug delivery are discussed by taking lipophilic prodrugs and dextran-conjugated macromolecular prodrugs of mitomycin C as an example.